OKYO Pharma Limited (OKYO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $70.85M
Last updated: Nov 17, 2026 at 11:05 AM ET
Earnings
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 16.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 33.6, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Data
Related GNG Research
No research available
Be the first to write about OKYO
News
OKYO Valuation
- P/FCF
- -4.8x
- P/B
- 3.6x
OKYO Profitability: Margins, ROIC and FCF
OKYO Pharma (OKYO) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -263.8%
- FCF yield
- -20.7%
OKYO Pharma Competitors
The companies most similar to OKYO Pharma (OKYO) include OUTLOOK THERAPEUTICS INC, Coya Therapeutics, Inc. Common Stock and Oncolytics Biotech.
Sector: Healthcare
OKYO Analyst Ratings
OKYO Pharma (OKYO) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 3
- Strong Buy
- 1
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong Sell
- 0
OKYO Bull Case vs Bear Case
Bear case
- OKYO beat EPS estimates in 16.7% of its last 6 reported quarters.
OKYO Earnings: Beat Rate and Next Report
- Beat rate
- 1 of 6 quarters (16.7%)
- Average surprise
- -36.3%
- EPS estimate (fiscal period ending Sep 30, 2026)
- -$0.04
- Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
- 0 up, 0 down
Updated Jul 25, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About OKYO
Does OKYO pay dividends?
OKYO Pharma Limited (OKYO) does not currently pay a regular dividend.
What is OKYO's market cap?
OKYO Pharma Limited (OKYO) has a market capitalization of $70.85M with a current stock price of $1.18.
How do analysts rate OKYO stock?
3 analysts cover OKYO Pharma Limited (OKYO): 1 rate it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, a consensus of Buy.
OKYO pages: Overview
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.